ArticleJournal of oncology2022

Overexpression of CDCP1 is Associated with Poor Prognosis and Enhanced Immune Checkpoints Expressions in Breast Cancer.

Jinlu Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.